Avalo Therapeutics, Inc.
Status: Publicly traded
Direct answer
Avalo Therapeutics, Inc. is publicly traded on NASDAQ under the ticker AVTX.
Avalo Therapeutics, Inc. is a precision medicine company in the clinical development phase, dedicated to identifying, advancing, and marketing specialized treatments for patients experiencing critical unmet medical needs across the fields of immunology, immuno-oncology, and rare genetic disorders. Among its key pipeline assets is AVTX-002, a fully human monoclonal antibody designed to inhibit LIGHT. This drug is...
Can you invest in Avalo Therapeutics, Inc.?
Yes. Avalo Therapeutics, Inc. trades publicly on NASDAQ as AVTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Avalo Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.